Clinical trial · Interventional
Myoinositol Plus L-tyrosine, Selenium and Chromium in PCOS
Use of Myoinositol Plus L-tyrosine, Selenium and Chromium in PCOS Women
NCT03673995CI-TRIAL-00045532completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
PCOS patients were treated every day, with one sachet containing 2000 mg myo-inositol, 500 mg L-tyrosine, 40 mcg chromium picolinate, 55 mcg selenium, 200 mcg folic acid. All patients underwent, before starting the therapy, after 3 months and 6 months, hormonal evaluation , hirsutism scoring and ovulation assesment. Most of them during the treatment improved their symptoms.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hirsutism | — | UNRESOLVED | — |
| Menstrual Problem | — | UNRESOLVED | — |
| Polycystic Ovary Syndrome | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Myo-inositol+L-tyrosine | Dietary Supplement | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Myo-inositol+L-tyrosine
- description
- One sachet per day containing 2000 mg myo-inositol, 500 mg L-tyrosine, 40 mcg chromium picolinate, 55 mcg selenium, 200 mcg folic acid for improving PCOS symptoms.
- interventionNames
- Dietary Supplement: Myo-inositol+L-tyrosine
Primary outcomes (1)
- measure
- Restore of regular menstrual period
- timeFrame
- 6 months of treatment
- description
- Self report
Secondary outcomes (2)
- measure
- Improving hirsutism
- timeFrame
- 6 months of treatment
- description
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 16 Years
- Maximum age
- 38 Years
Show eligibility criteria text
Inclusion Criteria: ° PCOS patients Exclusion Criteria: * thyroid dysfunction * hyperprolactinemia * adrenal hyperplasia * patients taking oral contraceptive * any other endocrinological pathologies
References
Publications (0)
Data not yet available
No reference posted for this study.